InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Tuesday, 12/10/2019 10:15:23 PM

Tuesday, December 10, 2019 10:15:23 PM

Post# of 179
News: $NVTA Invitae Announces Program with BioMarin to Expand Access to Genetic Testing for Skeletal Dysplasias

SAN FRANCISCO , Dec. 10, 2019 /PRNewswire/ --  Invitae (NYSE: NVTA), a leading medical genetics company, today announced the launch of Discover Dysplasias™ , an initiative with BioMarin Pharmaceutical to offer genetic testing at no charge to patients who show signs or symp...

Got this from NVTA - Invitae Announces Program with BioMarin to Expand Access to Genetic Testing for Skeletal Dysplasias